The shelf is now live, meaning selling stockholders can begin offloading shares at any time. Given the extreme overhang relative to the tiny float and going-concern risk, traders should expect continuous downward pressure. Avoid long positions and watch for any PR announcing a takedown or accelerated offering.
Price Chart
Executive Summary
Arcadia Biosciences' shelf registration (File No. 333-297072) became effective on July 8, 2026, enabling the resale of up to 11,922,333 shares registered under a prior S-3 filed in June 2026. This represents over 5x the current outstanding shares, creating an immediate and severe dilution overhang for a company with a $1M market cap and a going-concern warning.
Key Facts
- Shelf registration (File No. 333-297072) declared effective on July 8, 2026.
- Prior S-3 (June 2026) registered 11,922,333 shares for resale by selling stockholders, equating to >5x the current 2,181,715 shares outstanding.
- Company has a $1M market cap and a going-concern warning, amplifying the dilutive risk.
- The EFFECT allows the selling stockholders to immediately execute their resale, putting persistent downward pressure on the stock.
Financial Impact
Potential dilution of over 500% of current shares outstanding, enabled by this effectiveness notice.
Risk Factors
- Immediate share price decline from actual or anticipated selling by registered stockholders.
- Further dilution risk if the company itself conducts a takedown under the shelf.
- Potential for a reverse stock split or delisting if the stock price continues to deteriorate.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002229 |
| Document: 9999999995-26-002229-index.html | 9999999995-26-002229 |
| Document: 9999999995-26-002229.txt | 9999999995-26-002229 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 27d ago | SC 13G | $0.2800 | awaiting T+60 | — | $0.1598 (−42.93%) |
Sep 15, 2026 6w ago | 8-K | $0.4310 | awaiting T+60 | — | $0.1598 (−62.92%) |
Jul 9, 2026 15w ago | EFFECT | $0.6755 $0.2882 | ▲ +57.34% | ▲ +58.97% | $0.1598 (+76.34%) |
Jul 2, 2026 16w ago | 8-K | $0.7330 $0.3080 | ▼ −57.98% | ▼ −61.55% | $0.1598 (−78.20%) |
Jun 26, 2026 17w ago | S-3 | $0.7190 $0.4480 | ▲ +37.69% | ▲ +42.08% | $0.1598 (+77.77%) |
Jun 15, 2026 19w ago | 8-K | $0.9183 $0.4797 | ▲ +47.76% | ▲ +48.77% | $0.1598 (+82.60%) |
Jun 12, 2026 19w ago | Press Release | $0.9183 $0.4797 | ▲ +47.76% | ▲ +48.77% | $0.1598 (+82.60%) |
Jun 12, 2026 19w ago | Press Release | $0.9180 $0.4530 | ▲ +50.65% | ▲ +51.31% | $0.1598 (+82.59%) |
May 14, 2026 23w ago | 8-K | $0.9560 $0.6699 | ▲ +29.93% | ▲ +34.44% | $0.1598 (+83.28%) |
Apr 30, 2026 25w ago | 10-K/A | $1.12 $0.6300 | ▼ −43.75% | ▼ −46.82% | $0.1598 (−85.73%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers